Presentation Frequency of TVR With DCB vs Second-Generation DES for Coronary In-Stent Restenosis January 15, 2019 REGISTER for free or LOG IN to view this content Coronary DES/BRS/DCB Factoid Paclitaxel Paclitaxel DCB Stent Thrombosis Up Next Presentation ESC 2019 A Cluster Randomized Trial of Objective Risk Assessment Versus Standard Care for Acute Coronary Syndromes Presenter: David B. Brieger September 01, 2019 More slides + Presentation ESC 2019 A Risk Based Approach to the Role of Aspirin on Cardiovascular Risk Reduction in a Healthy Older Cohort Presenter: Christopher M Reid September 01, 2019 Presentation ESC 2019 Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction Primary Results of the PARAGON-HF Trial Presenter: Scott D. Solomon September 01, 2019 We Recommend
Presentation ESC 2019 A Cluster Randomized Trial of Objective Risk Assessment Versus Standard Care for Acute Coronary Syndromes Presenter: David B. Brieger September 01, 2019
Presentation ESC 2019 A Risk Based Approach to the Role of Aspirin on Cardiovascular Risk Reduction in a Healthy Older Cohort Presenter: Christopher M Reid September 01, 2019
Presentation ESC 2019 Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction Primary Results of the PARAGON-HF Trial Presenter: Scott D. Solomon September 01, 2019